Pharmacodynamics, safety, tolerability and pharmacokinetics of a single oral dose of an engineered phenylalanine ammonia-lyase in patients with phenylketonuria

The cornerstone treatment of hyperphenylalaninemia (HPA) and phenylketonuria (PKU) is a lifelong low-protein diet with phenylalanine (Phe) free L-amino acid supplements. However, the PKU diet has significant shortcomings, and there is a clinically unmet need for new therapeutics to improve patient o...

Full description

Bibliographic Details

Main Authors:	Timothy Nicholas Fazio, Louise Healy, Tim Heise, Anita Inwood, Catherine Manolikos, Yusof Rahman, Hans-Juergen Woerle, Christian J. Hendriksz
Format:	Artigo
Language:	Inglês
Published:	Elsevier 2023-12-01
Series:	Molecular Genetics and Metabolism Reports
Subjects:	Phenylketonuria CDX-6114 Enzyme Cinnamic acid Phenylalanine hydroxylase
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214426923000587
Tags:	Add Tag No Tags, Be the first to tag this record!